PARTNERSHIPS

MedAccess partners

Together with our partners, we leverage knowledge, experience and insight – enabling us to deploy appropriate financial products for the market, for our partners and ultimately for patients.

BASF logo

BASF

Our partnership has reduced the price of 35 million next-generation Interceptor G2 bed nets.

BASF
BMGF logo

Bill & Melinda Gates Foundation

We are working together to increase access to Interceptor G2 bed nets in malaria-endemic countries.

BMGF
CDC logo

CDC Group

MedAccess is a wholly owned subsidiary of CDC Group and forms a key component of the UK development finance institution’s Catalyst Strategies.

CDC Group
CHAI logo

Clinton Health Access Initiative

Our partnership has reduced the cost of Hologic’s Panther platform for HIV viral load testing by 40-50% in some markets.

CHAI
Dalberg logo

Dalberg

We partner on strategy and development impact, including working together closely to build our development impact framework.

Dalberg
FCDO logo

The Foreign, Commonwealth and Development Office

MedAccess is a wholly-owned subsidiary of the CDC Group which, in turn, is owned by the Foreign, Commonwealth and Development Office.

FCDO

Gavi, the Vaccine Alliance

Our agreement with Gavi enables the global vaccine alliance to support continued production of antigen for the RTS,S malaria vaccine by GSK in advance of key policy and funding decisions.

Gavi
Global Fund logo

The Global Fund to fight AIDS, Tuberculosis and Malaria

Our innovative finance for market-shaping helps the Global Fund to improve access to HIV, tuberculosis and malaria products.

The Global Fund
GSK logo

GSK

Our partnership with Gavi and GSK supports continued production of antigen for the RTS,S malaria vaccine ahead of key policy and funding decisions.

GSK
Hologic logo

Hologic

We are working together to increase access to viral load testing using the company’s Panther platform. Our partnership has resulted in a $12 ceiling price per patient test.

Hologic
IVCC logo

Innovative Vector Control Consortium

IVCC is the lead implementer in the New Nets Project, funded by the Global Fund and Unitaid.

IVCC

Macleods

Our volume guarantee is part of a package of measures to increase supply security and availability of Macleods’ 3HP short-course TB preventive therapy.

Macleods
SD Biosensor logo

SD Biosensor

Our volume guarantee will increase access to dual rapid testing for syphilis and HIV.

SD Biosensor
UK aid logo

UK government

Funding provided through UK aid improves access in lower -resource settings to products for infectious diseases such as HIV, TB and malaria by supporting us to enter into new partnerships.

UK aid
UNICEF logo

UNICEF

Our partnership is increasing and accelerating access to vital COVID-19 medical products, including diagnostic tests and clinical management supplies, in low- and middle-income countries.

UNICEF
UNITAID logo

Unitaid

We work with Unitaid on shaping markets for interventions against malaria and TB.

Unitaid